Health Care Down as Traders Bet on Growth Areas -- Health-Care Roundup

By Dow Jones Business News, 
A A A


Drug makers and health insurers fell slightly as traders hedged their bets on the outlook for deal activity and drug developments. Johnson & Johnson and Bayer AG announced plans Friday to launch clinical trials of the anticoagulant Xarelto against three new diseases in an ambitious bid to widen the market for a drug poised to exceed $1 billion in sales this year.

-Rob Curran, rob.curran@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires


  (END) Dow Jones Newswires
  08-29-141652ET
  Copyright (c) 2014 Dow Jones & Company, Inc.


This article appears in: News Headlines

Referenced Stocks: BAYN , BAYRY , JNJ

Dow Jones Business News


More from Dow Jones Business News:

Related Videos

Stocks

Referenced

80%

Most Active by Volume

74,573,823
  • $14.845 ▼ 1.75%
41,368,541
  • $56.51 ▲ 7.31%
38,054,052
  • $17.0281 ▲ 0.11%
36,239,473
  • $3.47 ▼ 2.25%
33,654,457
  • $14.095 ▼ 4.12%
28,010,716
  • $100.86 ▲ 0.75%
22,132,423
  • $4.91 ▼ 0.81%
20,144,438
  • $98.83 ▲ 0.18%
As of 9/30/2014, 12:36 PM